These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1243074

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hypolipemic activity of clofibrate-related compounds. 2nd Communication.
    Metz G, Specker M.
    Arzneimittelforschung; 1977 Jul; 27(7):1421-4. PubMed ID: 578466
    [Abstract] [Full Text] [Related]

  • 3. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
    Ginocchio AV, Metz G.
    Arzneimittelforschung; 1980 Jul; 30(11b):2032-4. PubMed ID: 7194054
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hypolipemic activity of plafibride.
    Bruseghini L, Vilageliu J, Bagaria A.
    Arzneimittelforschung; 1981 Jul; 31(10a):1796-800. PubMed ID: 7198456
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Potential hypolipidemic agents. XIX. Synthesis and lipid-lowering properties of thiophene derivatives related to clofibrate.
    Gronowitz S, Svenson R, Bondesson G, Magnusson O, Stjernström NE.
    Acta Pharm Suec; 1978 Jul; 15(5):361-7. PubMed ID: 747094
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pharmacology and toxicology of etofylline clofibrate].
    Sterner W, Korn WD.
    Arzneimittelforschung; 1980 Jul; 30(11b):2023-31. PubMed ID: 7194053
    [Abstract] [Full Text] [Related]

  • 13. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
    Maroto ML, Priego JG, Piña M, Catalán RE.
    Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives.
    Kawamatsu Y, Saraie T, Imamiya E, Nishikawa K, Hamuro Y.
    Arzneimittelforschung; 1980 Apr; 30(3):454-9. PubMed ID: 7387754
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
    Banzatti C, Branzoli U, Lovisolo PP, Melloni P, Orsini G, Salvadori P.
    Arzneimittelforschung; 1984 Apr; 34(8):864-9. PubMed ID: 6541922
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical effects and tolerance of etofylline clofibrate].
    Ziegler WJ, Metz G, Specker M.
    Arzneimittelforschung; 1980 Apr; 30(11b):2053-8. PubMed ID: 7194059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.